|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
08156 SINOPHARM TECH
Nominal 
0.000 (0.000%) | 2023/12 - Interim HKD(K$) | %Chg (Compare to Interim) | 2023/06 HKD(K$) | 2022/06 HKD(K$) | 2021/06 HKD(K$) | 2020/06 HKD(K$) | |
| Turnover | 18,844 | 25.418% | 42,839 | 40,985 | 77,813 | 165,934 |
| Cost of Sales | (15,723) | 31.178% | (37,369) | (35,053) | (56,929) | (121,281) |
| Gross Profit | 3,121 | 2.698% | 5,470 | 5,932 | 20,884 | 44,653 |
| 2023/12 - Interim HKD(K$) | %Chg (Compare to Interim) | 2023/06 HKD(K$) | 2022/06 HKD(K$) | 2021/06 HKD(K$) | 2020/06 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | 1,815 | -- | -- | (133,058) | |
| Profit / (Loss) on Disposal | -- | -- | (19,217) | -- | -- | -- | |
| Other Non-operating Items | -- | -- | (1,131) | (21,889) | (10,796) | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 186 | (153) | 3,588 | 558 | |
| Profit / (Loss) before Taxation | (2,239) | -- | (11,407) | (94,158) | (111,064) | (165,380) | |
| Taxation | 0 | -- | 1,307 | 387 | 558 | 1,390 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (637) | 76.454% | (535) | 5,773 | 4,166 | 2,915 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (2,876) | -- | (10,635) | (87,998) | (106,340) | (161,075) | |
| 2023/12 - Interim HKD(K$) | %Chg (Compare to Interim) | 2023/06 HKD(K$) | 2022/06 HKD(K$) | 2021/06 HKD(K$) | 2020/06 HKD(K$) | |
| Net Finance Costs / (Income) | 1,875 | -53.137% | 8,569 | 16,407 | 14,545 | 18,150 |
| Depreciation & Amortisation | 240 | -65.318% | 2,007 | 2,426 | 10,454 | 9,269 |
| Directors' Emoluments | -- | -- | 4,248 | 8,742 | 4,939 | 10,600 |
| 2023/12 - Interim | %Chg (Compare to Interim) | 2023/06 | 2022/06 | 2021/06 | 2020/06 | |
| Auditor's Opinion Status | N/A | -- | Qualified | Qualified | Unqualified (Modified Report) | Unqualified (Modified Report) |
Market Valuation Indicators
| 2023/12 - Interim | %Chg (Compare to Interim) | 2023/06 | 2022/06 | 2021/06 | 2020/06 | |
| EPS (cts) | -1.570 | -- | -0.060 | -49.000 | -61.750 | -97.750 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | 0.026 | (0.204) | (0.001) | 0.006 |
| NBV per share ($) | (0.960) | -- | (0.940) | (0.919) | (0.788377) | (0.425901) |
| Remarks: | Real time quote last updated: 25/11/2024 07:43 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders ($) | HKD -2,876,000 |
| %Change | -- |
| EPS / (LPS) | HKD -0.016 |
| NBV Per Share ($) | HKD -0.960 |